Bulletin
Investor Alert

Perrigo Co. PLC

NYS: PRGO

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

May 7, 2021, 6:26 p.m.

/zigman2/quotes/201110862/composite

$

43.08

Change

+0.12 +0.28%

Volume

Volume 25,416

Quotes are delayed by 20 min

/zigman2/quotes/201110862/composite

Previous close

$ 42.65

$ 42.96

Change

+0.31 +0.73%

Day low

Day high

$42.60

$43.46

Open

52 week low

52 week high

$38.20

$58.83

Open

Insider Actions for Perrigo Co. PLC

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
04/05/2021 Raymond P. Silcock
EVP, Chief Financial Officer
3,964   Derivative/Non-derivative trans. at $40.39 per share. 160,105
03/17/2021 Geoffrey M. Parker
Director
2,500   Acquisition at $41.29 per share. 103,225
03/10/2021 Ronald C. Janish
EVP, Gbl Ops & SC & CTO
2,662   Disposition at $41.23 per share. 109,754
03/08/2021 Todd W. Kingma
Executive VP, General Counsel
2,166   Derivative/Non-derivative trans. at $41.82 per share. 90,582
03/08/2021 Thomas M. Farrington
EVP and CIO
1,639   Derivative/Non-derivative trans. at $41.82 per share. 68,542
03/08/2021 Ronald C. Janish
EVP, Gbl Ops & SC & CTO
1,179   Derivative/Non-derivative trans. at $41.82 per share. 49,305
03/08/2021 Svend D. Andersen
EVP & President CHCI
47   Derivative/Non-derivative trans. at $41.82 per share. 1,965
03/08/2021 Grainne Quinn
EVP, Chief Medical Officer
1,083   Derivative/Non-derivative trans. at $41.82 per share. 45,291
03/08/2021 Robert Willis
EVP & CHRO
363   Derivative/Non-derivative trans. at $41.82 per share. 15,180
03/08/2021 Robert Willis
EVP & CHRO
980   Derivative/Non-derivative trans. at $41.82 per share. 40,983
03/08/2021 Todd W. Kingma
Executive VP, General Counsel
7,571   Award at $41.82 per share. 316,619
03/08/2021 Sharon Kochan
EVP & President Rx
4,721   Award at $41.82 per share. 197,432
03/08/2021 Thomas M. Farrington
EVP and CIO
3,758   Award at $41.82 per share. 157,159
03/08/2021 Ronald C. Janish
EVP, Gbl Ops & SC & CTO
4,121   Award at $41.82 per share. 172,340
03/08/2021 Svend D. Andersen
EVP & President CHCI
5,543   Award at $41.82 per share. 231,808
03/08/2021 Grainne Quinn
EVP, Chief Medical Officer
2,082   Award at $41.82 per share. 87,069
03/08/2021 Robert Willis
EVP & CHRO
1,884   Award at $41.82 per share. 78,788
03/08/2021 Robert Willis
EVP & CHRO
697   Derivative/Non-derivative trans. at $41.82 per share. 29,148
03/05/2021 Todd W. Kingma
Executive VP, General Counsel
667   Derivative/Non-derivative trans. at $41.04 per share. 27,373
03/05/2021 Todd W. Kingma
Executive VP, General Counsel
777   Derivative/Non-derivative trans. at $41.04 per share. 31,888
03/05/2021 Murray S. Kessler
CEO; Director
5,683   Derivative/Non-derivative trans. at $41.04 per share. 233,230
03/05/2021 Murray S. Kessler
CEO; Director
6,622   Derivative/Non-derivative trans. at $41.04 per share. 271,766
03/05/2021 Murray S. Kessler
CEO; Director
6,623   Derivative/Non-derivative trans. at $41.04 per share. 271,807
03/05/2021 Thomas M. Farrington
EVP and CIO
640   Derivative/Non-derivative trans. at $41.04 per share. 26,265
03/05/2021 Thomas M. Farrington
EVP and CIO
607   Derivative/Non-derivative trans. at $41.04 per share. 24,911
03/05/2021 Ronald C. Janish
EVP, Gbl Ops & SC & CTO
442   Derivative/Non-derivative trans. at $41.04 per share. 18,139
03/05/2021 Ronald C. Janish
EVP, Gbl Ops & SC & CTO
514   Derivative/Non-derivative trans. at $41.04 per share. 21,094
03/05/2021 Svend D. Andersen
EVP & President CHCI
37   Derivative/Non-derivative trans. at $41.04 per share. 1,518
03/05/2021 James E. Dillard
EVP, Chief Scientific Officer
570   Derivative/Non-derivative trans. at $41.04 per share. 23,392
03/05/2021 James E. Dillard
EVP, Chief Scientific Officer
666   Derivative/Non-derivative trans. at $41.04 per share. 27,332
03/05/2021 Grainne Quinn
EVP, Chief Medical Officer
548   Derivative/Non-derivative trans. at $41.04 per share. 22,489
03/05/2021 Grainne Quinn
EVP, Chief Medical Officer
638   Derivative/Non-derivative trans. at $41.04 per share. 26,183
03/05/2021 Robert Willis
EVP & CHRO
496   Derivative/Non-derivative trans. at $41.04 per share. 20,355
03/05/2021 Robert Willis
EVP & CHRO
286   Derivative/Non-derivative trans. at $41.04 per share. 11,737
03/05/2021 Robert Willis
EVP & CHRO
302   Derivative/Non-derivative trans. at $41.04 per share. 12,394
03/05/2021 Todd W. Kingma
Executive VP, General Counsel
2,540   Derivative/Non-derivative trans. at $41.04 per share. 104,241
03/05/2021 Todd W. Kingma
Executive VP, General Counsel
2,960   Derivative/Non-derivative trans. at $41.04 per share. 121,478
03/05/2021 Murray S. Kessler
CEO; Director
14,061   Derivative/Non-derivative trans. at $41.04 per share. 577,063
03/05/2021 Murray S. Kessler
CEO; Director
16,385   Derivative/Non-derivative trans. at $41.04 per share. 672,440
03/05/2021 Murray S. Kessler
CEO; Director
14,061   Derivative/Non-derivative trans. at $41.04 per share. 577,063
03/05/2021 Murray S. Kessler
CEO; Director
16,385   Derivative/Non-derivative trans. at $41.04 per share. 672,440
03/05/2021 Sharon Kochan
EVP & President Rx
1,996   Derivative/Non-derivative trans. at $41.04 per share. 81,915
03/05/2021 Sharon Kochan
EVP & President Rx
2,061   Derivative/Non-derivative trans. at $41.04 per share. 84,583
03/05/2021 Thomas M. Farrington
EVP and CIO
1,261   Derivative/Non-derivative trans. at $41.04 per share. 51,751
03/05/2021 Thomas M. Farrington
EVP and CIO
1,469   Derivative/Non-derivative trans. at $41.04 per share. 60,287
03/05/2021 Ronald C. Janish
EVP, Gbl Ops & SC & CTO
1,542   Derivative/Non-derivative trans. at $41.04 per share. 63,283
03/05/2021 Ronald C. Janish
EVP, Gbl Ops & SC & CTO
1,797   Derivative/Non-derivative trans. at $41.04 per share. 73,748
03/05/2021 Svend D. Andersen
EVP & President CHCI
2,540   Derivative/Non-derivative trans. at $41.04 per share. 104,241
03/05/2021 Svend D. Andersen
EVP & President CHCI
2,960   Derivative/Non-derivative trans. at $41.04 per share. 121,478
03/05/2021 Richard S. Sorota
EVP & President CSCA
2,540   Derivative/Non-derivative trans. at $41.04 per share. 104,241
03/05/2021 James E. Dillard
EVP, Chief Scientific Officer
1,996   Derivative/Non-derivative trans. at $41.04 per share. 81,915
03/05/2021 James E. Dillard
EVP, Chief Scientific Officer
2,326   Derivative/Non-derivative trans. at $41.04 per share. 95,459
03/05/2021 Raymond P. Silcock
EVP, Chief Financial Officer
3,629   Derivative/Non-derivative trans. at $41.04 per share. 148,934
03/05/2021 Grainne Quinn
EVP, Chief Medical Officer
1,053   Derivative/Non-derivative trans. at $41.04 per share. 43,215
03/05/2021 Grainne Quinn
EVP, Chief Medical Officer
1,226   Derivative/Non-derivative trans. at $41.04 per share. 50,315
03/05/2021 Robert Willis
EVP & CHRO
953   Derivative/Non-derivative trans. at $41.04 per share. 39,111
03/05/2021 Robert Willis
EVP & CHRO
550   Derivative/Non-derivative trans. at $41.04 per share. 22,572
03/05/2021 Robert Willis
EVP & CHRO
580   Derivative/Non-derivative trans. at $41.04 per share. 23,803
03/05/2021 Murray S. Kessler
CEO; Director
5,683   Derivative/Non-derivative trans. at $41.04 per share. 233,230
03/05/2021 Svend D. Andersen
EVP & President CHCI
55   Derivative/Non-derivative trans. at $41.04 per share. 2,257
03/05/2021 Richard S. Sorota
EVP & President CSCA
1,108   Derivative/Non-derivative trans. at $41.04 per share. 45,472
02/05/2021 James E. Dillard
EVP, Chief Scientific Officer
1,396   Derivative/Non-derivative trans. at $43.09 per share. 60,153
02/05/2021 James E. Dillard
EVP, Chief Scientific Officer
4,297   Derivative/Non-derivative trans. at $0 per share. 0
01/06/2021 Richard S. Sorota
EVP & President CSCA
7,513   Acquisition at $43.48 per share. 326,665
11/09/2020 Theodore Rapp Samuels
Director
4,500   Acquisition at $46.91 per share. 211,095
11/09/2020 Rolf Allan Classon
Director
2,137   Acquisition at $46.75 per share. 99,904
08/14/2020 Robert Willis
EVP & CHRO
303   Derivative/Non-derivative trans. at $53.4 per share. 16,180
08/14/2020 Robert Willis
EVP & CHRO
581   Derivative/Non-derivative trans. at $53.4 per share. 31,025
08/11/2020 Svend D. Andersen
EVP & President CHCI
2,828   Acquisition at $53.01 per share. 149,912

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
36 Purchases
25 Sales
140,558
36,237
Last 6 months
40 Purchases
26 Sales
159,005
37,633
Last 12 months
58 Purchases
42 Sales
223,317
64,378

Officers and Executives

Mr. Murray S. Kessler
President, Chief Executive Officer & Director
Mr. Raymond P. Silcock
CFO, Principal Accounting Officer & Executive VP
Mr. Thomas M. Farrington
Chief Information Officer & Executive VP
Dr. Grainne Quinn
Chief Medical Officer & Executive Vice President
Mr. James E. Dillard
Chief Scientific Officer & Executive VP
Mr. Richard S. Sorota
President-Consumer Self Care Americas & EVP
Ms. Sharon Kochan
EVP, President-RX Pharmaceuticals
Mr. Svend D. Andersen
EVP & President-Consumer Selfcare International
Mr. Ronald C. Janish
Chief Transformation Officer
Mr. Louis K. Cherico
Treasurer & Vice President
Mr. Bradley Joseph
Vice President-Global Investor Relations
Mr. Robert Willis
Chief Human Resources Officer & Executive VP
Mr. Todd W. Kingma
Secretary, Executive VP & General Counsel
Mr. Rolf Allan Classon
Chairman
Ms. Katherine C. Doyle
Independent Director
Mr. Orlando D. Ashford
Independent Director
Mr. Donal M. O'Connor
Independent Director
Mr. Geoffrey M. Parker
Independent Director
Mr. Theodore Rapp Samuels
Independent Director
Mr. Bradley A. Alford
Independent, Director
Mr. Jeffrey B. Kindler
Independent Director
Ms. Adriana Karaboutis
Independent Director
Ms. Erica L. Mann
Independent Director
Trending Tickers
  • /quotes/zigman/17636479/composite VUZI+15.60%
  • /quotes/zigman/237947/composite JCP-5.83%
  • /quotes/zigman/59392505/composite NUGT-2.93%
  • /quotes/zigman/59386294/composite JNUG-5.94%
  • /quotes/zigman/65801738/composite TLT+1.11%
X
Powered by StockTwits
Link to MarketWatch's Slice.